Vijoice
Payments companies reported to CMS as associated with Vijoice. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vijoice, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vijoice
These are the largest totals companies reported as associated with Vijoice. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Joyce Teng | Palo Alto, CA | Pediatric Dermatology | $11,868.03 |
| Autumn Atkinson | Houston, TX | Pediatrics | $6,924.98 |
| Alexandra Borst | Nashville, TN | Pediatric Hematology-Oncology | $6,562.50 |
| Adrienne Hammill | Cincinnati, OH | Pediatric Hematology-Oncology | $5,991.99 |
| Ionela Iacobas | Houston, TX | Pediatrics | $5,937.50 |
| Netta Schneller | Houston, TX | Pediatric Hematology-Oncology | $5,726.97 |
| Bryan Sisk | Saint Louis, MO | Pediatric Hematology-Oncology | $5,474.03 |
| Amir Pezeshkmehr | Little Rock, AR | Pediatric Radiology | $5,385.84 |
| Kristy Rialon | Houston, TX | Pediatric Surgery | $4,952.71 |
| Nathan Schloemer | Milwaukee, WI | Pediatrics | $4,367.96 |
Prescribed Vijoice?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.